Ensysce Biosciences Inc ENSC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 11/26/21 EST
1.59quote price arrow up+0.01 (+0.63%)
Close
1.58quote price arrow down-0.12 (-7.06%)
Volume
108,807
52 week range
1.37 - 23.99
Loading...
  • Open1.70
  • Day High1.72
  • Day Low1.58
  • Prev Close1.70
  • 52 Week High23.99
  • 52 Week High Date02/01/21
  • 52 Week Low1.37
  • 52 Week Low Date11/22/21

Key Stats

  • Market Cap38.33M
  • Shares Out24.26M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta-0.23
  • YTD % Change-87.29

KEY STATS

  • Open1.70
  • Day High1.72
  • Day Low1.58
  • Prev Close1.70
  • 52 Week High23.99
  • 52 Week High Date02/01/21
  • 52 Week Low1.37
  • 52 Week Low Date11/22/21
  • Market Cap38.33M
  • Shares Out24.26M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta-0.23
  • YTD % Change-87.29

RATIOS/PROFITABILITY

  • EPS (TTM)-0.58
  • P/E (TTM)-2.75
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-1.359M
  • ROE (TTM)3.19%
  • Revenue (TTM)700,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)20.30%
  • Debt To Equity (MRQ)8.61%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ensysce Biosciences Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Ensysce Biosciences, Inc., formerly Leisure Acquisition Corp., is a clinical-stage biotech company. The Company is engaged in the development of small and large molecule drug delivery platforms targeting pain and cancer markets. The primary focus of the Company is its small molecule program developing abuse and overdose resistant pain technology with a clinical stage program being the abuse resistant, trypsin activated abuse protection (TAAP) opioid product candidate, PF614....
Address
7946 Ivanhoe Avenue, Suite 201
La Jolla, CA
92037
United States